Funds and ETFs Kyowa Kirin Co. Ltd.

Equities

4151

JP3256000005

Pharmaceuticals

Delayed Japan Exchange 02:00:00 2024-06-10 am EDT 5-day change 1st Jan Change
2,728 JPY +0.85% Intraday chart for Kyowa Kirin Co. Ltd. +1.75% +15.08%

ETFs positioned on Kyowa Kirin Co. Ltd.

Name Weight AuM 1st Jan change Investor Rating
2.22% 14 M€ +13.21%
0.44% 10 M€ +16.91% -
0.41% 240 M€ +19.42%
0.39% 28,050 M€ +17.67% -
0.36% 62,153 M€ +17.63%
0.36% 14,619 M€ +16.71% -
0.30% 25 M€ +16.42%
0.26% 69 M€ +17.98%
0.23% 57 M€ +20.14%
0.20% 0 M€ 0.00% -
0.17% 4,931 M€ +18.92%
0.17% 9,764 M€ +19.33%
0.15% 17 M€ +16.94% -
0.15% 14 M€ +5.66% -
0.15% 5 M€ +10.09% -
0.13% 19,753 M€ +17.73% -
0.13% 138,841 M€ +18.91%
0.12% 29 M€ +8.37% -
0.10% 469 M€ -2.05%
0.10% 3,859 M€ +18.82% -
0.09% 4 M€ -.--% -
0.03% 7 M€ +0.11% -
0.03% 10 M€ -3.35% -
0.03% 7 M€ +5.53% -
0.02% 261 M€ -.--% -
0.02% 200 M€ +11.72% -
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows: - sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment; - sales of licenses (7.4%). At the end of 2021, the group had 3 production sites located in Japan (2) and China. Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,704 JPY
Average target price
3,054 JPY
Spread / Average Target
+12.93%
Consensus
  1. Stock Market
  2. Equities
  3. 4151 Stock
  4. Funds and ETFs Kyowa Kirin Co. Ltd.